HUP0700433A2 - Compounds influencing development or functioning of cellular vesicular systems particularly lipid droplets, pharmaceutical compositions containing these compounds and use them for treatment of illnesses - Google Patents

Compounds influencing development or functioning of cellular vesicular systems particularly lipid droplets, pharmaceutical compositions containing these compounds and use them for treatment of illnesses

Info

Publication number
HUP0700433A2
HUP0700433A2 HU0700433A HUP0700433A HUP0700433A2 HU P0700433 A2 HUP0700433 A2 HU P0700433A2 HU 0700433 A HU0700433 A HU 0700433A HU P0700433 A HUP0700433 A HU P0700433A HU P0700433 A2 HUP0700433 A2 HU P0700433A2
Authority
HU
Hungary
Prior art keywords
compounds
illnesses
functioning
treatment
pharmaceutical compositions
Prior art date
Application number
HU0700433A
Other languages
English (en)
Inventor
Laszlo Dr Puskas
Liliana Feher
Eszter Molnar
Original Assignee
Avidin Kutato
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avidin Kutato filed Critical Avidin Kutato
Priority to HU0700433A priority Critical patent/HUP0700433A2/hu
Publication of HU0700433D0 publication Critical patent/HU0700433D0/hu
Priority to CA002691522A priority patent/CA2691522A1/en
Priority to EA201070040A priority patent/EA201070040A1/ru
Priority to PCT/HU2008/000075 priority patent/WO2008155594A2/en
Priority to US12/452,206 priority patent/US8232299B2/en
Priority to BRPI0813501-0A2A priority patent/BRPI0813501A2/pt
Priority to EP08776241A priority patent/EP2373618A2/en
Priority to AU2008264918A priority patent/AU2008264918A1/en
Priority to CN200880103820A priority patent/CN101784523A/zh
Priority to JP2010512785A priority patent/JP2010530410A/ja
Publication of HUP0700433A2 publication Critical patent/HUP0700433A2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU0700433A 2007-06-21 2007-06-21 Compounds influencing development or functioning of cellular vesicular systems particularly lipid droplets, pharmaceutical compositions containing these compounds and use them for treatment of illnesses HUP0700433A2 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
HU0700433A HUP0700433A2 (en) 2007-06-21 2007-06-21 Compounds influencing development or functioning of cellular vesicular systems particularly lipid droplets, pharmaceutical compositions containing these compounds and use them for treatment of illnesses
JP2010512785A JP2010530410A (ja) 2007-06-21 2008-06-20 新規化合物、小胞系に影響を及ぼす化合物、医薬組成物及びその使用
US12/452,206 US8232299B2 (en) 2007-06-21 2008-06-20 Phthalimide derivatives that influence cellular vesicular systems, pharmaceutical compositions, and use thereof
EA201070040A EA201070040A1 (ru) 2007-06-21 2008-06-20 Новые соединения, соединения, которые влияют на клеточные везикулярные системы, фармацевтические композиции и их применение
PCT/HU2008/000075 WO2008155594A2 (en) 2007-06-21 2008-06-20 Phthalimide derivatives that influence cellular vesicular systems, pharmaceutical compositions, and use thereof
CA002691522A CA2691522A1 (en) 2007-06-21 2008-06-20 Phthalimide derivatives that influence cellular vesicular systems, pharmaceutical compositions, and use thereof
BRPI0813501-0A2A BRPI0813501A2 (pt) 2007-06-21 2008-06-20 Compostos, compostos que influenciam sistemas vesiculares celulares, composições farmacêuticas e uso dos mesmos
EP08776241A EP2373618A2 (en) 2007-06-21 2008-06-20 Phthalimide derivatives that influence cellular vesicular systems, pharmaceutical compositions, and use thereof
AU2008264918A AU2008264918A1 (en) 2007-06-21 2008-06-20 Phthalimide derivatives that influence cellular vesicular systems, pharmaceutical compositions, and use thereof
CN200880103820A CN101784523A (zh) 2007-06-21 2008-06-20 影响细胞囊泡系统的邻苯二甲酰亚胺衍生物、药物组合物及其用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0700433A HUP0700433A2 (en) 2007-06-21 2007-06-21 Compounds influencing development or functioning of cellular vesicular systems particularly lipid droplets, pharmaceutical compositions containing these compounds and use them for treatment of illnesses

Publications (2)

Publication Number Publication Date
HU0700433D0 HU0700433D0 (en) 2007-08-28
HUP0700433A2 true HUP0700433A2 (en) 2009-03-30

Family

ID=89987602

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0700433A HUP0700433A2 (en) 2007-06-21 2007-06-21 Compounds influencing development or functioning of cellular vesicular systems particularly lipid droplets, pharmaceutical compositions containing these compounds and use them for treatment of illnesses

Country Status (10)

Country Link
US (1) US8232299B2 (hu)
EP (1) EP2373618A2 (hu)
JP (1) JP2010530410A (hu)
CN (1) CN101784523A (hu)
AU (1) AU2008264918A1 (hu)
BR (1) BRPI0813501A2 (hu)
CA (1) CA2691522A1 (hu)
EA (1) EA201070040A1 (hu)
HU (1) HUP0700433A2 (hu)
WO (1) WO2008155594A2 (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP1000688A2 (en) * 2010-12-23 2012-08-28 Avidin Kft Use of trifluoro-phthalimides in the treatment of cancer
US20150376538A1 (en) * 2013-03-06 2015-12-31 Jx Nippon Oil & Energy Corporation Friction modifier and lubricating oil composition
US20170283408A1 (en) * 2014-09-19 2017-10-05 Yen-Ta Lu Benzo-heterocyclic compounds and their applications

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673699A (en) * 1984-11-19 1987-06-16 Mobay Corporation Flame retardant molding compositions

Also Published As

Publication number Publication date
US8232299B2 (en) 2012-07-31
AU2008264918A1 (en) 2008-12-24
HU0700433D0 (en) 2007-08-28
JP2010530410A (ja) 2010-09-09
CA2691522A1 (en) 2008-12-24
EA201070040A1 (ru) 2010-06-30
CN101784523A (zh) 2010-07-21
WO2008155594A2 (en) 2008-12-24
US20100184762A1 (en) 2010-07-22
BRPI0813501A2 (pt) 2015-01-06
EP2373618A2 (en) 2011-10-12
WO2008155594A3 (en) 2009-02-12

Similar Documents

Publication Publication Date Title
IL219380A (en) Converted 2-sulfonamidophenyl compounds n-Aryl propionamide-preserved, processes for their preparation, medications containing them, and uses @ them
IL198289A (en) Processed dihydropyrazolones, processes for their preparation, medicinal preparations containing them and their use in the preparation of medicinal preparations
IL199397A (en) Hetero-ring compounds, pharmaceuticals containing them, and their medicinal products
IL233677A (en) Benzysacazole Compounds Aminopyrazolo-Primidine Converted, Pharmaceuticals Containing Them, and Use of Drug Manufacturing Composition
IL225198A (en) Aminotetrahydropyrenic Compounds, Pharmaceutical Preparations Containing Them and Their Use in the Treatment of Diabetes
IL202505A (en) 2-oxo-3-benzyl-benzoxazole-2-one derivatives and related compounds as met kinase inhibitors for the treatment of tumors, drugs containing them and their uses
IL194005A0 (en) Stable nanocapsulate systems for the administration of active molecules
IL199362A (en) Pyridopyrimidine Compounds, Pharmaceuticals, Compounds for Use as a Drug, and Compounds for Manufacture @ Drug
IL196280A0 (en) Use of ampk-activating imidazole derivatives, preparation process therefor and pharmaceutical compositions comprising them
IL199835A (en) Acid-activated antimicrobial peptides, their pharmaceutical preparations, and their use in drug preparation
IL212435A (en) Isoindulin compounds, their pharmaceutical compositions and their use in the preparation of drugs
IL200116A0 (en) Compounds and pharmaceutical compositions for the treatment of viral infections
IL192763A (en) History of pyrimidine, preparations containing them and used in the preparation of cancer drugs
IL198301A (en) Aryl amides are stored in thiazole and oxazole, a pharmaceutical preparation containing them and their use in the preparation of drugs
IL197933A (en) Knaase inhibitors, pharmaceuticals containing them and their uses
NO20090295L (no) Substituerte heteroarylderivater
AP2007004247A0 (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
WO2008013838A3 (en) Pyridizinone derivatives
PL2076244T3 (pl) Układy wodne do wytwarzania związków farmaceutycznych na bazie lipidów; kompozycje, sposoby, oraz ich zastosowanie
IL185277A0 (en) Pharmaceutical compositions containing roflumilast for the treatment of diabetes
IL197877A (en) Uses of aminomethyl-4-imidazole derivatives for the preparation of medications and medications containing them
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
MX2009005909A (es) Sal fumarato de (alfa s, beta r)-6-bromo-alfa-[2-(dimetilamino)eti l]-2-metoxi-alfa-1-naftalenil-beta-fenil-3-quinolinaetanol.
HK1134902A1 (en) Compounds a-r-x for the manufacture of pharmaceutical preparations
MX2009004017A (es) Usos de los compuestos carboxi-amido triazol y sus sales.

Legal Events

Date Code Title Description
FH91 Appointment of a representative

Free format text: FORMER REPRESENTATIVE(S): DR. KOVARI ZOLTAN, ADVOPATENT SZABADALMI ES VEDJEGY IRODA, HU

Representative=s name: KOVARI ES TARSAI SZABADALMI ES VEDJEGY IRODA K, HU

FH92 Termination of representative

Representative=s name: DR. KOVARI ZOLTAN, ADVOPATENT SZABADALMI ES VE, HU

FD9A Lapse of provisional protection due to non-payment of fees